MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 91 filers reported holding MEIRAGTX HLDGS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,882 | -26.9% | 1,809 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $12,156 | -1.3% | 1,809 | -4.2% | 0.00% | 0.0% |
| Q4 2022 | $12,310 | -14.5% | 1,888 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $14,406 | -45.3% | 1,903 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $26,357 | -85.1% | 1,903 | -74.4% | 0.00% | -50.0% |
| Q4 2021 | $176,578 | +80.1% | 7,438 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $98,033 | +12.4% | 7,438 | +23.1% | 0.00% | 0.0% |
| Q1 2021 | $87,186 | -21.4% | 6,042 | -17.5% | 0.00% | -50.0% |
| Q4 2020 | $110,855 | +20.9% | 7,322 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $91,671 | +4.9% | 7,322 | +33.6% | 0.00% | +100.0% |
| Q3 2019 | $87,390 | -31.1% | 5,479 | +16.1% | 0.00% | -50.0% |
| Q2 2019 | $126,900 | +56.0% | 4,721 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $81,343 | – | 4,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
| Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
| Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
| Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
| Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
| 683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
| Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
| Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
| PA Capital LLC | 39,039 | $525,000 | 0.46% |